Author: Bin Lou; Tigndong Li; Shufa Zheng; Yingying Su; Zhiyong Li; Wei Liu; Fei Yu; Shengxiang Ge; Qianda Zou; Quan Yuan; Sha Lin; Congming Hong; Xiangyang Yao; Xuejie Zhang; Dinghui Wu; Guoliang Zhou; Wangheng Hou; Tingting Li; Yali Zhang; Shiyin Zhang; Jian Fan; Jun Zhang; Ningshao Xia; Yu Chen
Title: Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset Document date: 2020_3_27
ID: ndpuezpo_31
Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.23.20041707 doi: medRxiv preprint exposure were assigned into the short incubation period group and the remaining patients were assigned into the long incubation period group (Table 4 ). There was no significant difference on age, viral load in the early stage of illness and the risk of critical status between the groups. However, the med.....
Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.23.20041707 doi: medRxiv preprint exposure were assigned into the short incubation period group and the remaining patients were assigned into the long incubation period group (Table 4 ). There was no significant difference on age, viral load in the early stage of illness and the risk of critical status between the groups. However, the median seroconversion time was shorter for the short incubation period group than for the long incubation period group (13d.p.e v.s. 21d.p.e, p<0.001). In contrast, the median seroconversion day post onset was longer for the short incubation period group than the long incubation period
Search related documents:
Co phrase search for related documents- critical status and incubation period: 1, 2
- critical status and period group: 1, 2, 3
- critical status and significant difference: 1, 2, 3
- critical status and viral load: 1, 2
- early stage and illness early stage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
- early stage and illness early stage viral load: 1
- early stage and incubation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- early stage and long incubation period: 1, 2
- early stage and median seroconversion time: 1, 2
- early stage and period group: 1, 2, 3, 4, 5
- early stage and post onset: 1, 2, 3, 4, 5, 6, 7
- early stage and remain patient: 1
- early stage and seroconversion time: 1, 2
- early stage and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- early stage and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51
- group critical status and period group: 1, 2
- illness early stage and median seroconversion time: 1, 2
- illness early stage and post onset: 1, 2, 3, 4
- illness early stage and seroconversion time: 1, 2
Co phrase search for related documents, hyperlinks ordered by date